Article
Roflumilast attenuates neuroinflammation post retinal ischemia/reperfusion injury by regulating microglia phenotype via the Nrf2/STING/NF-κB pathway.
International immunopharmacology - 1 Nov 2023
Guo Yuyan, Ou Chunlian, Zhang Naiyuan, Liu Qiong, Xiong Ke, Yu Jian, Cheng Hao, Chen Linjiang, Ma Ming, Xu Jing, Wu Jing
Abstract excerpt
PURPOSE: The abnormal polarisation of microglial cells (MGs) following retinal ischemia/reperfusion (RIR) initiates neuroinflammation and progressive death of retinal ganglion cells (RGCs), causing increasingly severe and irreversible visual dysfunction. Roflumilast (Roflu) is a promising candidate for treating neuroinflammatory diseases. This study aimed to explore whether Roflu displayed a cytoprotective effect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
